9999999995-20-001404.txt : 20200612 9999999995-20-001404.hdr.sgml : 20200612 20200612001510 ACCESSION NUMBER: 9999999995-20-001404 CONFORMED SUBMISSION TYPE: EFFECT PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20200611 DATE AS OF CHANGE: 20200612 EFFECTIVENESS DATE: 20200611 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SELLAS Life Sciences Group, Inc. CENTRAL INDEX KEY: 0001390478 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: EFFECT SEC ACT: 1933 Act SEC FILE NUMBER: 333-238799 FILM NUMBER: 20958743 BUSINESS ADDRESS: STREET 1: 15 WEST 38TH STREET STREET 2: 10TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 BUSINESS PHONE: (917) 438-4353 MAIL ADDRESS: STREET 1: 15 WEST 38TH STREET STREET 2: 10TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 FORMER COMPANY: FORMER CONFORMED NAME: Galena Biopharma, Inc. DATE OF NAME CHANGE: 20110926 FORMER COMPANY: FORMER CONFORMED NAME: RXi Pharmaceuticals Corp DATE OF NAME CHANGE: 20110926 FORMER COMPANY: FORMER CONFORMED NAME: GALENA BIOPHARMA, INC. DATE OF NAME CHANGE: 20110922 EFFECT 1 primary_doc.xml X0101 EFFECT 33 LIVE 2020-06-11 16:00:00

S-1

0001390478 SELLAS Life Sciences Group, Inc. 333-238799